Browse diseases

…nd after chemotherapy. This study examined how DMT decisions in breast cancer influence MS outcomes and whether chemotherapy itself affects M…

…Background We aimed to investigate the prodromal phase of multiple sclerosis (MS) by investigating annual sickness absence rates before MS o…

…Background Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin…

…ht chain (KFLC) index has emerged as a diagnostic biomarker for multiple sclerosis (MS). This study aims to evaluate the diagnostic accuracy of th…

…ion (aHSCT) represents a treatment option for highly aggressive multiple sclerosis (MS). Here, we report outcome analyses from the two largest Ger…

… Higher vitamin D has consistently been associated with a lower multiple sclerosis (MS) risk, but some controversy remains about whether this is d…

…Background Patients aged ≥35 years at multiple sclerosis (MS) onset with an Expanded Disability Status Scale (EDSS) ≥3 i…

…lerosis(MS) and psoriasis. We propose that the co-occurrence of psoriasis and MS (PsoMS) represents a distinct clinical variant of MS,cha…

…Background The link between multiple sclerosis (MS) and Epstein-Barr virus (EBV) is well established in adults…

…rrelates with reduced relapse rates and increased disability in multiple sclerosis (MS). Biological age may better capture ageing’s impact on MS a…

…between 1st and 2nd relapse (p=0.03). Last-recorded Age-Related Multiple Sclerosis Severity Score was also associated with immune TRS, (p=0.03) wh…

…Background Multiple sclerosis (MS) progression independent of relapses is driven by brain inn…